Novo Nordisk CEO Mike Doustdar Talks Drug Sales

Novo Nordisk CEO Mike Doustdar Talks Drug Sales

0 Umsagnir
0
Episode
2403 of 2425
Lengd
9Mín.
Tungumál
enska
Gerð
Flokkur
Viðskiptabækur

Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far.

See omnystudio.com/listener for privacy information.


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
Prófa frítt
is Device Banner Block 894x1036
Cover for Novo Nordisk CEO Mike Doustdar Talks Drug Sales

Other podcasts you might like ...